-
1
-
-
0041497693
-
Differential expression of epidermal growth factor receptor in human head and neck cancers
-
Ke LD, Adler-Storthz K, Clayman GL, et al. Differential expression of epidermal growth factor receptor in human head and neck cancers. Head Neck 1998;20:320-7.
-
(1998)
Head Neck
, vol.20
, pp. 320-327
-
-
Ke, L.D.1
Adler-Storthz, K.2
Clayman, G.L.3
-
2
-
-
0032478998
-
Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival
-
Rubin Grandis J, Melhem MF, Gooding WE, et al. Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival. J Natl Cancer Inst 1998;90:824-32.
-
(1998)
J Natl Cancer Inst
, vol.90
, pp. 824-832
-
-
Rubin Grandis, J.1
Melhem, M.F.2
Gooding, W.E.3
-
3
-
-
0029831041
-
Quantitative immunohistochemical analysis of transforming growth factor-alpha and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck
-
Rubin Grandis J, Melhem MF, Barnes EL, et al. Quantitative immunohistochemical analysis of transforming growth factor-alpha and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck. Cancer 1996;78:1284-92.
-
(1996)
Cancer
, vol.78
, pp. 1284-1292
-
-
Rubin Grandis, J.1
Melhem, M.F.2
Barnes, E.L.3
-
4
-
-
0037115674
-
Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma
-
Ang KK, Berkey BA, Tu X, et al. Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma. Cancer Res 2002;62:7350-6. (Pubitemid 36025259)
-
(2002)
Cancer Research
, vol.62
, Issue.24
, pp. 7350-7356
-
-
Ang, K.K.1
Berkey, B.A.2
Tu, X.3
Zhang, H.-Z.4
Katz, R.5
Hammond, E.H.6
Fu, K.K.7
Milas, L.8
-
5
-
-
17844393104
-
The effect of ZD1839 (Iressa), an epidermal growth factor receptor tyrosine kinase inhibitor, in combination with cisplatin, on apoptosis in SCC-15 cells
-
Al-Hazzaa A, Bowen ID, Randerson P, et al. The effect of ZD1839 (Iressa), an epidermal growth factor receptor tyrosine kinase inhibitor, in combination with cisplatin, on apoptosis in SCC-15 cells. Cell Prolif 2005;38:77-86.
-
(2005)
Cell Prolif
, vol.38
, pp. 77-86
-
-
Al-Hazzaa, A.1
Bowen, I.D.2
Randerson, P.3
-
6
-
-
0036681995
-
Modulation of radiation response and tumor-induced angiogenesis after epidermal growth factor receptor inhibition by ZD1839 (Iressa)
-
Huang SM, Li J, Armstrong EA, et al. Modulation of radiation response and tumor-induced angiogenesis after epidermal growth factor receptor inhibition by ZD1839 (Iressa). Cancer Res 2002;62:4300-6. (Pubitemid 34827286)
-
(2002)
Cancer Research
, vol.62
, Issue.15
, pp. 4300-4306
-
-
Huang, S.-M.1
Li, J.2
Armstrong, E.A.3
Harari, P.M.4
-
7
-
-
0037674062
-
Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck
-
Cohen EE, Rosen F, Stadler WM, et al. Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck. J Clin Oncol 2003;21:1980-7.
-
(2003)
J Clin Oncol
, vol.21
, pp. 1980-1987
-
-
Cohen, E.E.1
Rosen, F.2
Stadler, W.M.3
-
8
-
-
28544432807
-
Phase II trial of gefitinib 250 mg daily in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck
-
Cohen EE, Kane MA, List MA, et al. Phase II trial of gefitinib 250 mg daily in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck. Clin Cancer Res 2005;11:8418-24.
-
(2005)
Clin Cancer Res
, vol.11
, pp. 8418-8424
-
-
Cohen, E.E.1
Kane, M.A.2
List, M.A.3
-
9
-
-
64649097892
-
Phase III study of gefitinib 250 compared with intravenous methotrexate for recurrent squamous cell carcinoma of the head and neck
-
Stewart JS, Cohen EE, Licitra L, et al. Phase III study of gefitinib 250 compared with intravenous methotrexate for recurrent squamous cell carcinoma of the head and neck. J Clin Oncol 2009;27:1864-71.
-
(2009)
J Clin Oncol
, vol.27
, pp. 1864-1871
-
-
Stewart, J.S.1
Cohen, E.E.2
Licitra, L.3
-
10
-
-
0034681783
-
Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data
-
MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer
-
Pignon JP, Bourhis J, Domenge C, et al. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet 2000;355:949-55.
-
(2000)
Lancet
, vol.355
, pp. 949-955
-
-
Pignon, J.P.1
Bourhis, J.2
Domenge, C.3
-
11
-
-
0030457015
-
Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced head and neck carcinoma: Final report of a randomized trial
-
Bachaud JM, Cohen-Jonathan E, Alzieu C, et al. Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced head and neck carcinoma: final report of a randomized trial. Int J Radiat Oncol Biol Phys 1996;36:999-1004.
-
(1996)
Int J Radiat Oncol Biol Phys
, vol.36
, pp. 999-1004
-
-
Bachaud, J.M.1
Cohen-Jonathan, E.2
Alzieu, C.3
-
13
-
-
0036139727
-
Pharmacodynamic studies of the epidermal growth factor receptor inhibitor ZD1839 in skin from cancer patients: Histopathologic and molecular consequences of receptor inhibition
-
Albanell J, Rojo F, Averbuch S, et al. Pharmacodynamic studies of the epidermal growth factor receptor inhibitor ZD1839 in skin from cancer patients: histopathologic and molecular consequences of receptor inhibition. J Clin Oncol 2002;21:110-24.
-
(2002)
J Clin Oncol
, vol.21
, pp. 110-124
-
-
Albanell, J.1
Rojo, F.2
Averbuch, S.3
-
14
-
-
1842579584
-
Serum KIT and KIT ligand levels in patients with gastrointestinal stromal tumors treated with imatinib
-
Bono P, Krause A, von Mehren M, et al. Serum KIT and KIT ligand levels in patients with gastrointestinal stromal tumors treated with imatinib. Blood 2004;103:2929-35.
-
(2004)
Blood
, vol.103
, pp. 2929-2935
-
-
Bono, P.1
Krause, A.2
Von Mehren, M.3
-
15
-
-
63149103474
-
Surrogate endpoints in head and neck cancer
-
Chen L, Cohen EE. Surrogate endpoints in head and neck cancer. Lancet Oncol 2009;10:309-10.
-
(2009)
Lancet Oncol
, vol.10
, pp. 309-310
-
-
Chen, L.1
Cohen, E.E.2
-
16
-
-
62349097073
-
Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck: A phase I/II study
-
Cohen EE, Davis DW, Karrison TG, et al. Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck: a phase I/II study. Lancet Oncol 2009;10:247-57.
-
(2009)
Lancet Oncol
, vol.10
, pp. 247-257
-
-
Cohen, E.E.1
Davis, D.W.2
Karrison, T.G.3
-
17
-
-
29144446003
-
Epidermal growth factor receptor directed therapy in head and neck cancer
-
Choong NW, Cohen EE. Epidermal growth factor receptor directed therapy in head and neck cancer. Crit Rev Oncol Hematol 2006;57:25-43.
-
(2006)
Crit Rev Oncol Hematol
, vol.57
, pp. 25-43
-
-
Choong, N.W.1
Cohen, E.E.2
-
18
-
-
63449130280
-
Genetic signatures of HPV-related and unrelated oropharyngeal carcinoma and their prognostic implications
-
Klussmann JP, Mooren JJ, Lehnen M, et al. Genetic signatures of HPV-related and unrelated oropharyngeal carcinoma and their prognostic implications. Clin Cancer Res 2009;15:1779-86.
-
(2009)
Clin Cancer Res
, vol.15
, pp. 1779-1786
-
-
Klussmann, J.P.1
Mooren, J.J.2
Lehnen, M.3
-
19
-
-
0032719534
-
Inverse relationship between epidermal growth factor receptor expression and radiocurability of murine carcinomas
-
Akimoto T, Hunter NR, Buchmiller L, et al. Inverse relationship between epidermal growth factor receptor expression and radio-curability of murine carcinomas. Clin Cancer Res 1999;5:2884-90. (Pubitemid 29493967)
-
(1999)
Clinical Cancer Research
, vol.5
, Issue.10
, pp. 2884-2890
-
-
Akimoto, T.1
Hunter, N.R.2
Buchmiller, L.3
Mason, K.4
Ang, K.K.5
Milas, L.6
-
20
-
-
0000091450
-
The effect of ionizing radiation on signal transduction: Antibodies to EGF receptor sensitize A431 cells to radiation
-
Balaban N, Moni J, Shannon M, et al. The effect of ionizing radiation on signal transduction: antibodies to EGF receptor sensitize A431 cells to radiation. Biochim Biophys Acta 1996; 1314:147-56.
-
(1996)
Biochim Biophys Acta
, vol.1314
, pp. 147-156
-
-
Balaban, N.1
Moni, J.2
Shannon, M.3
-
21
-
-
0030772168
-
Radiation-induced proliferation of the human A431 squamous carcinoma cells is dependent on EGFR tyrosine phosphorylation
-
Schmidt-Ullrich RK, Mikkelsen RB, Dent P, et al. Radiation-induced proliferation of the human A431 squamous carcinoma cells is dependent on EGFR tyrosine phosphorylation. Oncogene 1997;15:1191-7.
-
(1997)
Oncogene
, vol.15
, pp. 1191-1197
-
-
Schmidt-Ullrich, R.K.1
Mikkelsen, R.B.2
Dent, P.3
-
22
-
-
32144433159
-
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck
-
Bonner JA, Harari PM, Giralt J, et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 2006;354:567-78.
-
(2006)
N Engl J Med
, vol.354
, pp. 567-578
-
-
Bonner, J.A.1
Harari, P.M.2
Giralt, J.3
-
23
-
-
4644345181
-
Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy
-
Chua DT, Nicholls JM, Sham JS, et al. Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy. Int J Radiat Oncol Biol Phys 2004;59:11-20.
-
(2004)
Int J Radiat Oncol Biol Phys
, vol.59
, pp. 11-20
-
-
Chua, D.T.1
Nicholls, J.M.2
Sham, J.S.3
|